Related Experiment Video
Updated: Jun 4, 2025

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis
Published on: May 19, 2021
Boldine reduces left ventricle oxidative stress in isoproterenol-induced adrenergic overload experimental model
Elissa Kerli Fernandes1, Patrick Türck1, Cristina Campos Carraro1
1Laboratory of Cardiovascular Physiology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil.
Insights
Boldine (BOL) protects the heart from damage caused by sustained adrenergic overload. BOL treatment reduced cardiac hypertrophy and oxidative stress, suggesting a therapeutic role in preventing adverse cardiac remodelling.
Area of Science:
- Cardiology
- Pharmacology
- Oxidative Stress Research
Background:
- Sustained adrenergic overload leads to maladaptive cardiac remodelling and oxidative stress.
- Boldine (BOL), an antioxidant, presents a potential therapeutic strategy for cardiac conditions.
Purpose of the Study:
- To investigate the cardioprotective effects of Boldine (BOL) against isoproterenol (ISO)-induced adverse left ventricular remodelling.
- To evaluate BOL's impact on cardiac hypertrophy, diastolic dysfunction, and oxidative stress markers.
Main Methods:
- Rats were divided into control, BOL, isoproterenol (ISO), and ISO + BOL groups.
- Evaluated morphometric, echocardiographic, and oxidative stress parameters.
- Assessed lipid peroxidation, superoxide dismutase (SOD), and glutathione-S-transferase (GST) levels.
Main Results:
- BOL significantly attenuated cardiac hypertrophy and increased diastolic volume induced by ISO (P < 0.05).
- BOL treatment reduced ISO-induced lipid peroxidation (P < 0.05).
- BOL administration increased superoxide dismutase (SOD) and glutathione-S-transferase (GST) levels (P < 0.05).
Conclusions:
- Boldine (BOL) demonstrates cardioprotective effects against isoproterenol-induced cardiac remodelling.
- BOL may improve cardiac oxidative stress by enhancing antioxidant enzyme activity.
- BOL shows promise as a therapeutic agent for conditions involving adrenergic overload and cardiac remodeling.
Abstract:
Sustained adrenergic overload in the heart causes maladaptive cardiac remodelling, which involves oxidative stress. Boldine (BOL) has antioxidant activity and represents a novel therapeutic approach. This study explored the cardioprotective role of BOL in adverse left ventricular remodelling induced by isoproterenol. The rats were divided into four groups: control; BOL (25 mg/kg daily); isoproterenol (ISO) (5 mg/kg daily), and ISO + BOL. Morphometric, echocardiographic, and oxidative stress parameters were evaluated. BOL attenuated both cardiac hypertrophy and increased diastolic volume caused by adrenergic overstimulation (P < 0.05). BOL treatment reduced lipid peroxidation induced by ISO (ISO vs. ISO + BOL; P < 0.05), and this effect was associated with increased superoxide dismutase (SOD) (ISO vs. ISO + BOL; P < 0.05) and glutathione-S-transferase levels (GST) (ISO vs. ISO + BOL; P < 0.05). This data suggest that BOL may improve cardiac oxidative stress and attenuate some parameters of adverse cardiac remodelling.
Related Concept Videos
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Inotropic Agents
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...

